Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C1887> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- NCIT_C1887 IAO_0000115 "A recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC)." @default.
- NCIT_C1887 NCIT_A32 NCIT_C1909 @default.
- NCIT_C1887 NCIT_A7 NCIT_C17279 @default.
- NCIT_C1887 NCIT_NHC0 "C1887" @default.
- NCIT_C1887 NCIT_P106 "Amino Acid, Peptide, or Protein" @default.
- NCIT_C1887 NCIT_P106 "Immunologic Factor" @default.
- NCIT_C1887 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C1887 NCIT_P107 "Epratuzumab" @default.
- NCIT_C1887 NCIT_P108 "Epratuzumab" @default.
- NCIT_C1887 NCIT_P175 "716711" @default.
- NCIT_C1887 NCIT_P207 "C1120776" @default.
- NCIT_C1887 NCIT_P210 "205923-57-5" @default.
- NCIT_C1887 NCIT_P302 "Systemic lupus erythematosus" @default.
- NCIT_C1887 NCIT_P319 "3062P60MH9" @default.
- NCIT_C1887 NCIT_P322 "CTRP" @default.
- NCIT_C1887 NCIT_P322 "FDA" @default.
- NCIT_C1887 NCIT_P322 "GDC" @default.
- NCIT_C1887 NCIT_P329 "42234" @default.
- NCIT_C1887 NCIT_P330 "42234" @default.
- NCIT_C1887 NCIT_P366 "Epratuzumab" @default.
- NCIT_C1887 NCIT_P375 "Epratuzumab" @default.
- NCIT_C1887 NCIT_P399 "42234" @default.
- NCIT_C1887 NCIT_R124 NCIT_C17710 @default.
- NCIT_C1887 NCIT_R124 NCIT_C17828 @default.
- NCIT_C1887 NCIT_R124 NCIT_C18219 @default.
- NCIT_C1887 NCIT_R124 NCIT_C19986 @default.
- NCIT_C1887 NCIT_R124 NCIT_C40474 @default.
- NCIT_C1887 normalizedInformationContent "92.730304365937428" @default.
- NCIT_C1887 referenceCount "3" @default.
- NCIT_C1887 hasExactSynonym "AMG 412" @default.
- NCIT_C1887 hasExactSynonym "EPRATUZUMAB" @default.
- NCIT_C1887 hasExactSynonym "Epratuzumab" @default.
- NCIT_C1887 hasExactSynonym "IMMU-HLL2" @default.
- NCIT_C1887 hasExactSynonym "LymphoCide" @default.
- NCIT_C1887 hasExactSynonym "epratuzumab" @default.
- NCIT_C1887 hasExactSynonym "hLL2" @default.
- NCIT_C1887 inSubset NCIT_C116977 @default.
- NCIT_C1887 inSubset NCIT_C116978 @default.
- NCIT_C1887 inSubset NCIT_C128784 @default.
- NCIT_C1887 inSubset NCIT_C157711 @default.
- NCIT_C1887 inSubset NCIT_C157712 @default.
- NCIT_C1887 inSubset NCIT_C176424 @default.
- NCIT_C1887 inSubset NCIT_C177537 @default.
- NCIT_C1887 inSubset NCIT_C63923 @default.
- NCIT_C1887 type Class @default.
- NCIT_C1887 isDefinedBy ncit.owl @default.
- NCIT_C1887 label "Epratuzumab" @default.
- NCIT_C1887 subClassOf NCIT_C129821 @default.
- NCIT_C1887 subClassOf NCIT_C129822 @default.
- NCIT_C1887 subClassOf NCIT_C1887 @default.
- NCIT_C1887 subClassOf NCIT_C1908 @default.
- NCIT_C1887 subClassOf NCIT_C1909 @default.
- NCIT_C1887 subClassOf NCIT_C20401 @default.
- NCIT_C1887 subClassOf NCIT_C274 @default.
- NCIT_C1887 subClassOf NCIT_C307 @default.
- NCIT_C1887 subClassOf NCIT_C308 @default.